Searchable abstracts of presentations at key conferences in endocrinology

ea0035p943 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

The impact of the Cushing's Disease remission in associated comorbidities

Fernandes Vera , Santos Maria J , Almeida Rui , Marques Olinda

Background: The Cushing’s disease (CD) is associated with comorbidities that have a significant impact on patients’ quality of life. However, it is not known the true impact of the disease remission on these comorbidities.Objectives: To assess the evolution of comorbidities associated with CD, after its remission.Methods: It was done an observational, analytical and retrospective study of patients with CD in remission, fo...

ea0011p720 | Reproduction | ECE2006

Screening for gene SRY by FISH in patients with Turner Syndrome

Guimarães J , Almeida Santos T , Barbosa A , Bastos M , Almeida Santos A , Carvalheiro M

Turner’s Syndrome is one of the most common chromosomal abnormalities found in 1 in 2500 live female births. Y chromosome material is detected in up to 6% of patients by karyotype, but with new technologies (DNA analysis), Y chrmosome sequences have been reported in 60% of patients. The presence of Y material has been associated with virilization and with the development of gonadal neoplasia.Aim: Determine the frequency of Y chromosome sequences in ...

ea0070ep265 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Diabetic gastroparesis as an important comorbidity factor: About a clinical case

Veríssimo David , Faustino Diogo , Lopes da Costa Inês , Pires Pedro , Marques Carmen , Almeida Júlio

Introduction: Gastroparesis associated with diabetic autonomic neuropathy is an underdiagnosed complication, although relatively common in diabetes. It is more prevalent in type 1 Diabetes Mellitus (DM1) with more than ten years of disease and especially in patients with poor metabolic control.Clinical case: Female, 37 years old, DM1 with 17 years of evolution with poor metabolic control (HbA1c 9.3%) and several microvascular complications such as prolif...